New Internal Survey Shows GoodRx Helps Pharmacies as Well as Consumers

At GoodRx, we want a healthcare system where everyone thrives. That’s why we work to make sure we bring value to both consumers and to our partners.

To better understand how pharmacies benefit from GoodRx, we recently conducted an internal survey of over 4,000 GoodRx and GoodRx Gold users about their experience getting prescriptions and making other purchases at the pharmacy counter. What we found is that medication affordability benefits not only consumers but could also benefit pharmacies.

About a quarter of those surveyed reported that they could afford all of their prescriptions before using GoodRx or GoodRx Gold. After using GoodRx or GoodRx Gold, that number jumped to over 80%. By helping consumers afford their prescriptions, we may help pharmacies reduce “walk away” patients and prescriptions abandoned at the counter due to high cost. These lower costs can also make it more likely that consumers will take their medications as prescribed (also known as adherence), which improves their health outcomes.

It also turns out that GoodRx helped survey respondents form a positive impression of their pharmacy experience, and they reported making additional trips because of GoodRx. Of those surveyed, 85% agreed that having a positive experience with GoodRx at their preferred pharmacy made them want to return to that pharmacy more often. What’s more, over 60% of those surveyed said they visit the pharmacy at least once a month, and about a quarter reported making additional trips to a pharmacy because of GoodRx.

And respondents who visit pharmacies to use GoodRx coupons reported buying other non-prescription items. In the same survey, about 75% of consumers said they purchased non-prescription items when picking up a prescription. About half of these people also spent more than $40 on non-prescription items.

These survey results indicate that GoodRx may benefit both consumers and the pharmacies where they fill their prescriptions. 

Forward-looking statements

This post contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this post do not relate to matters of historical fact and should be considered forward-looking statements, including without limitation statements regarding and the benefits of GoodRx’s offerings for pharmacy retailers and GoodRx’s impact on the healthcare ecosystem. 

These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties, and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks related to our limited operating history and early stage of growth; our ability to achieve broad market education and change consumer purchasing habits; our ability to continue to attract, acquire, and retain consumers in a cost-effective manner; our reliance on our prescription offering and ability to expand our offerings; changes in medication pricing and pricing structures; and the important factors discussed under the caption “Risk Factors” in GoodRx’s Annual Report on Form 10-K for the year ended December 31, 2020, and our other filings with the SEC. 

These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this post. Any such forward-looking statements represent management’s estimates as of the date of this post. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change